Charles River Laboratories International, Inc. today launched a full, end-to-end service offering of CRISPR/Cas9 genome engineering technology. Read More
Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
Recently at BioPharm America 2016 in Boston, September 13-15, biotech start-up company Asymmetrex announced its new AlphaSTEM Test contract service for counting adult tissue stem cells. In addition to applications for... Read More
Looking to hire? Interested in promoting your synthetic biology related studies? Become a Career Fair Exhibitor at the Giant Jamboree and meet with iGEM's exceptional talent from around the globe. Register by July 30th... Read More
Among the challenges to faster progress in gene-editing therapeutics is the requirement that corrections of inherited genetic mutations occur in tissue stem cells. Last week on May 4-5 at the Precision Medicine Symposium-2016... Read More
Asymmetrex continues to pursue gene-editing companies to offer technologies for quantifying edited tissue stem cells and increasing their number. Read More
On March 22, Boston stem cell medicine technology start-up Asymmetrex will present a free, public, online webinar with the goal of discussing how it developed a stem cell technology that has been needed since the beginnings... Read More
As 2015 drew to a close, stem cell medicine biotechnology start-up company Asymmetrex began an effort to educate the pharmaceutical and regenerative medicine industries on the value of counting adult tissue stem cells.... Read More